Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Browse by Speaker
Home
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
M
Mager, Donald
Univ at Buffalo, SUNY School of Pharmacy & Pharmaceutical Sciences
Invited Keynote: Benefit vs Risk: What's the Optimal Dose of Artificial Intelligence in Clinical Pharmacology?
Location:Grand Ballroom E-K
Donald Mager
Favorite
Symposium 1: Dose Individualization of Biologics to Improve Patient Outcome: A Joint ACCP/EACPT Symposium
Location:Grand Ballroom E-H
Donald Mager
Favorite
1 - Introduction
Donald Mager
Favorite
1 - Introduction & Clinical Pharmacology Considerations of Biologics: Fundamentals & Principles
Donald Mager
Favorite
Mehta, Khamir
Amgen Inc
Symposium 7: Are Mechanistic Models Necessary or Nice-to-Have in the Development of Multispecific Antibodies?
Location:Grand Ballroom E-H
Khamir Mehta
Favorite
5 - Case Studies in Mechanism-based Models for Immune-oncology
Khamir Mehta
Favorite
Meyers, Rachel
Rutgers Univ
Symposium 9: Enteral Feeding & Soft Foods: Supporting Medication Dosing in Pediatrics & the Hospitalized
Location:Grand Ballroom I-K
Rachel Meyers
Favorite
1 - It’s a Jungle Out There: Administering Medications With Enteral Feeding & Soft Foods to Pediatric Patients in the Real World
Rachel Meyers
Favorite
Momper, Jeremiah
Univ of California San Diego
Symposium 5: Contemporary Issues Related to Pediatric Drug Development
Location:Grand Ballroom E-H
Jeremiah Momper
Favorite
3 - Considerations for Neonatal Clinical Pharmacology Studies
Jeremiah Momper
Favorite
Mould, Diane
Projections Research Inc
Symposium 1: Dose Individualization of Biologics to Improve Patient Outcome: A Joint ACCP/EACPT Symposium
Location:Grand Ballroom E-H
Diane Mould
Favorite
4 - Can We Improve Outcomes for Biologics in Inflammatory Bowel Disease? YES! (and we can reduce cost)
Diane Mould
Favorite
Mullick, Charu
US Food & Drug Administration
Symposium 2: HIV Pre-exposure Prophylaxis: Evolving Clinical Practice & Product Development Guided by Clinical Pharmacology
Location:Grand Ballroom I-K
Charu Mullick
Favorite
4 - Pivotal Clinical PrEP Trial Innovations: Considering Counterfactual Study Design & Innovative Control Groups
Charu Mullick
Favorite
Musante, Cynthia
Pfizer Worldwide Research, Development & Medical Clinical Pharmacology & Bioanalytics
Invited Keynote: Benefit vs Risk: What's the Optimal Dose of Artificial Intelligence in Clinical Pharmacology?
Location:Grand Ballroom E-K
Cynthia Musante
Favorite
2 - Benefit vs Risk: What’s the Optimal Dose of Artificial Intelligence in Clinical Pharmacology?
Cynthia Musante
Favorite
